| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
26,320,000 |
| Market
Cap: |
66.06(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.05 - $4.81 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Neuronetics is a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Co.'s commercial product, NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical power designed to stimulate specific areas of the brain associated with mood. The system is used to treat adult patients with major depressive disorder (MDD) who have failed to achieve improvement from prior antidepressant medication in the existing MDD episode.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
28,500 |
212,868 |
| Total Buy Value |
$0 |
$0 |
$51,671 |
$532,557 |
| Total People Bought |
0 |
0 |
1 |
2 |
| Total Buy Transactions |
0 |
0 |
1 |
16 |
| Total Shares Sold |
155,132 |
235,560 |
275,113 |
945,067 |
| Total Sell Value |
$496,907 |
$733,721 |
$821,850 |
$4,759,069 |
| Total People Sold |
3 |
3 |
4 |
5 |
| Total Sell Transactions |
9 |
17 |
24 |
55 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shook Bruce Joseph |
Director |
– • – |
2020-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
27,500 |
27,500 |
|
- |
|
| Bakewell John K |
Director |
– • – |
2020-05-26 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
4,050 |
|
- |
|
| Muir Glenn P |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
63,723 |
|
- |
|
| Jaeger Wilfred E |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
37,639 |
|
- |
|
| Blanchard Cheryl R |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
34,437 |
|
- |
|
| Farley Brian E |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
242,606 |
|
- |
|
| Bakewell John K |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
| Conley Sheryl L |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
33,244 |
|
- |
|
| Guthrie Daniel |
Chief Commercial Officer |
• – – |
2020-05-22 |
4 |
D |
$1.94 |
$5,190 |
D/D |
(2,675) |
144,180 |
|
- |
|
| Farley Brian E |
Director |
– • – |
2020-03-13 |
4 |
B |
$2.28 |
$91,200 |
D/D |
40,000 |
217,606 |
2.39 |
44% |
|
| Farley Brian E |
Director |
– • – |
2020-03-12 |
4 |
B |
$2.18 |
$21,800 |
D/D |
10,000 |
177,606 |
2.39 |
51% |
|
| Guthrie Daniel |
Chief Commercial Officer |
• – – |
2020-03-12 |
4 |
B |
$2.36 |
$11,800 |
D/D |
5,000 |
146,855 |
2.74 |
51% |
|
| Macan William Andrew |
Sr. VP, GC, CCO and Secretary |
• – – |
2020-03-10 |
4 |
B |
$2.00 |
$10,000 |
D/D |
5,000 |
182,399 |
2.74 |
47% |
|
| Guthrie Daniel |
Chief Commercial Officer |
• – – |
2020-03-10 |
4 |
D |
$2.01 |
$1,445 |
D/D |
(719) |
141,855 |
|
- |
|
| Harper Gregory |
VP of R&D, Ops. and Prod. Dev. |
• – – |
2020-03-10 |
4 |
D |
$2.00 |
$2,036 |
D/D |
(1,018) |
153,962 |
|
- |
|
| Furlong Stephen |
VP and CFO |
• – – |
2020-03-10 |
4 |
B |
$2.00 |
$50,000 |
D/D |
25,000 |
274,184 |
2.74 |
47% |
|
| Tropsha Yelena |
VP of Commercial Access |
• – – |
2020-03-10 |
4 |
D |
$1.98 |
$1,778 |
D/D |
(898) |
65,987 |
|
- |
|
| Furlong Stephen |
VP and CFO |
• – – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
65,250 |
249,184 |
|
- |
|
| Harper Gregory |
VP of R&D, Ops. and Prod. Dev. |
• – – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
44,500 |
154,980 |
|
- |
|
| Guthrie Daniel |
Chief Commercial Officer |
• – – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
56,500 |
142,574 |
|
- |
|
| Tropsha Yelena |
VP of Commercial Access |
• – – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
38,750 |
66,885 |
|
- |
|
| Macan William Andrew |
Sr. VP, GC, CCO and Secretary |
• – – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
76,250 |
177,399 |
|
- |
|
| Farley Brian E |
Director |
– • – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
167,606 |
|
- |
|
| Thatcher Christopher |
President and CEO |
• • – |
2020-03-04 |
4 |
OE |
$0.87 |
$17,400 |
D/D |
20,000 |
249,811 |
|
- |
|
| Macan William Andrew |
Sr. VP, GC, CCO and Secretary |
• – – |
2020-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
101,149 |
101,149 |
|
- |
|
260 Records found
|
|
Page 8 of 11 |
|
|
0.02 (0.8%) 
